Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|June 5, 2008
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccinesTanja D de Gruijl, Alfons J M van den Eertwegh, Herbert M Pinedo, et al.
Molecular Cancer Therapeutics|October 17, 2007
O6-methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor induced resistance against temozolomide in human melanoma cellsDennis Fontijn, Auke D Adema, Kishor K Bhakat, et al.
International Journal of Cancer|July 13, 2002
Novel camptothecin derivative BNP1350 in experimental human ovarian cancer: determination of efficacy and possible mechanisms of resistanceAnnemarie H Van Hattum, Hennie M M Schlüper, Frederick H Hausheer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignanciesBart C Kuenen, Giuseppe Giaccone, Rita Ruijter, et al.
International Journal of Cancer|March 3, 2007
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancerRobert Mauritz, Cees J van Groeningen, Kees Smid, et al.
The Journal of Biological Chemistry|December 17, 2002
Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arseniteMonique C A Duyndam, Saskia T M Hulscher, Elsken van der Wall, et al.
Oncology (Williston Park, N.Y.)|February 9, 2002
Immunologic and biologic properties of the primary tumor during prolonged neoadjuvant chemoimmunotherapyEvelien Bodar, Jan Buter, Tanja D de Gruijl, et al.
Biochemical Pharmacology|October 23, 2004
A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapyMichelle de Graaf, Tapio J Nevalainen, Hans W Scheeren, et al.
Cancer Research|November 5, 2002
Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potencyVictor W van Beusechem, Petra B van den Doel, Jacques Grill, et al.
European Journal of Pharmacology|May 14, 2004
The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylaseMichiel De Bruin, Toni Van Capel, Kees Smid, et al.
Pageof 8